Trump to announce drug-pricing deal with Pfizer, new ‘TrumpRx’ website

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00
(Adobe Stock)

President Donald Trump on Tuesday will announce an agreement with pharmaceutical giant Pfizer to voluntarily sell its medications through Medicaid at lower prices.

The White House also will unveil a new website, dubbed TrumpRx, to allow direct-to-consumer sales of medications at discounted rates, the administration said in a statement.

The announcements are part of the White House’s push to secure “Most Favored Nation” pricing deals with pharmaceutical manufacturers, an effort to link U.S. drug prices to the lowest cost of drugs paid by the wealthiest countries. Trump in May signed an executive order that laid out the initiative, and administration officials have been negotiating with pharmaceutical companies in a bid to get them to voluntarily lower their prices. The deadline for those voluntary agreements was Monday.

Trump has long argued that the United States government spends too much on medications and pursued a similar drug-pricing plan during his first term. His administration has sought to pressure the pharmaceutical industry through a mix of tariffs and new initiatives, such as several pilot programs being developed by the Centers for Medicare and Medicaid Services that could impose new drug-pricing controls in the Medicare program, according to four people who spoke on the condition of anonymity to detail those pilot programs.

“We pay much higher for drugs than the rest of the world. We subsidize the rest of the world,” Trump said in remarks last week. “We’re not doing that anymore and that’s a big thing.”

Trump sent letters in July to 17 pharmaceutical companies, calling on them to lower their drug prices within 60 days.

“Democrats talked the talk for decades about drug prices, but only President Trump is actually walking the walk,” White House spokesman Kush Desai said in a written statement.

The pharmaceutical industry has sought to blunt Trump’s demands by making concessions. The industry’s main lobbying group, the Pharmaceutical Research and Manufacturers of America, on Monday announced voluntary steps that it said would support Trump’s goals, including a new website intended to help Americans shop for lower-priced drugs.

Pfizer also plans to announce a $70 billion investment in research and development and domestic manufacturing, the White House said.

“It’s a win for American patients, a win for American leadership, and it’s a win for Pfizer because it provides the certainty and stability we need to continue advancing new breakthrough medicines for patients,” said Pfizer spokesman Kit Maher.

For its part, Indianapolis-based drug manufacturer Eli Lilly and Co. in recent weeks has announced two multibillion-dollar manufacturing plants in the U.S.—in Virginia and Texas—with plans for two more announcements this year. The plants are part of a $27 billion reshoring effort announced earlier this year.

Democrats have said that they share Trump’s goals for lower drug prices, but have criticized his reliance on executive orders to achieve them and called for comprehensive legislation. Sen. Bernie Sanders, I-Vermont, on Monday issued a report that found 87 drugs increased in price after Trump sent the letters to drug manufacturers.

“In his second term, Trump once again says he wants to lower prices on prescription drugs. But prescription drug prices keep increasing,” Sanders wrote in the report.

Please enable JavaScript to view this content.

Story Continues Below

6 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

    1. He (or his kids) will sue after his term claiming that, because it used their name, it thereby their property. They will use public resources to build it and then privatize it to themselves, just like the Russian oligarchy did.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In